Reproductive Healthcare in Women with Rheumatoid Arthritis and
Psoriatic Diseases in Routine Clinical Practice: Survey Results
of Rheumatologists and Dermatologists

J 2022

Reproductive Healthcare in Women with Rheumatoid Arthritis and Psoriatic Diseases in Routine Clinical Practice: Survey Results of Rheumatologists and Dermatologists

OLEJAROVA, Marta, Zelmira MACEJOVA, Spyridon GKALPAKIOTIS, Leona PROCHÁZKOVÁ, Zoltan TOTH et. al.

Basic information

Original name

Reproductive Healthcare in Women with Rheumatoid Arthritis and Psoriatic Diseases in Routine Clinical Practice: Survey Results of Rheumatologists and Dermatologists

Authors

OLEJAROVA, Marta (203 Czech Republic, guarantor), Zelmira MACEJOVA (203 Czech Republic), Spyridon GKALPAKIOTIS, Leona PROCHÁZKOVÁ (203 Czech Republic, belonging to the institution), Zoltan TOTH and Pavel PRAGR (203 Czech Republic)

Edition

RHEUMATOLOGY AND THERAPY, NEW YORK, SPRINGER, 2022, 2198-6576

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30226 Rheumatology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 3.800

RIV identification code

RIV/00216224:14110/22:00128213

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1007/s40744-022-00488-z

UT WoS

000857814200002

Keywords in English

Women of childbearing age; Family planning; Chronic inflammatory disease; Rheumatoid arthritis; Psoriatic arthritis; Psoriasis; Reproductive health

Abstract

V originále

Introduction The proportion of women being treated with biologics is growing. However, data on treatment recommendation awareness among treating physicians and women who are considering pregnancy and family planning are limited. In this study, we used a questionnaire survey to learn how rheumatologists and dermatologists address women's needs for family planning, pregnancy, and breastfeeding, as well as their possible concerns with concurrent inflammatory rheumatic disease or psoriasis. Methods A 55-question (in English) survey aimed at identifying surveyed physicians' current practices regarding the reproductive health needs of women with rheumatoid arthritis, psoriasis, or psoriatic arthritis. This survey included 82 rheumatologists and 38 dermatologists from the Czech Republic, Hungary, and Slovakia. Results The proportion of female patients of reproductive age with the moderate-to-severe disease was 10-30% of all patients treated by the respondents. At the time of diagnosis, approximately two-thirds of the respondents discussed family planning with their patients. Rheumatologists collaborated with other specialists more frequently than dermatologists and gynecologist-obstetricians. Half of the rheumatologists revised systemic treatment 6 months before the patient planned to become pregnant, whereas dermatologists appear to act much sooner. Rheumatologists chose systemic glucocorticoids as the first-line treatment for pregnancy flares, whereas dermatologists chose topical corticosteroids. Congresses and interdisciplinary forums were rated the most valuable sources of information by physicians. Conclusions There is a need for more holistic, multidisciplinary, collaborative, and integrated communication between clinicians and women of childbearing age. Physicians should consider the implications of these conditions and medical treatment for women of childbearing age and family planning for those with rheumatoid arthritis and psoriatic disease. Patient-centered care that includes patients' reproductive choices should be a routine clinical practice.

Citovat

OLEJAROVA, Marta, Zelmira MACEJOVA, Spyridon GKALPAKIOTIS, Leona PROCHÁZKOVÁ, Zoltan TOTH and Pavel PRAGR. Reproductive Healthcare in Women with Rheumatoid Arthritis and Psoriatic Diseases in Routine Clinical Practice: Survey Results of Rheumatologists and Dermatologists. RHEUMATOLOGY AND THERAPY. NEW YORK: SPRINGER, 2022, vol. 9, No 6, p. 1575-1586. ISSN 2198-6576. Available from: https://dx.doi.org/10.1007/s40744-022-00488-z.

@article{2249066,
   author = {Olejarova, Marta and Macejova, Zelmira and Gkalpakiotis, Spyridon and Procházková, Leona and Toth, Zoltan and Pragr, Pavel},
   article_location = {NEW YORK},
   article_number = {6},
   doi = {http://dx.doi.org/10.1007/s40744-022-00488-z},
   keywords = {Women of childbearing age; Family planning; Chronic inflammatory disease; Rheumatoid arthritis; Psoriatic arthritis; Psoriasis; Reproductive health},
   language = {eng},
   issn = {2198-6576},
   journal = {RHEUMATOLOGY AND THERAPY},
   title = {Reproductive Healthcare in Women with Rheumatoid Arthritis and Psoriatic Diseases in Routine Clinical Practice: Survey Results of Rheumatologists and Dermatologists},
   url = {https://link.springer.com/article/10.1007/s40744-022-00488-z},
   volume = {9},
   year = {2022}
}

TY  - JOUR
ID  - 2249066
AU  - Olejarova, Marta - Macejova, Zelmira - Gkalpakiotis, Spyridon - Procházková, Leona - Toth, Zoltan - Pragr, Pavel
PY  - 2022
TI  - Reproductive Healthcare in Women with Rheumatoid Arthritis and Psoriatic Diseases in Routine Clinical Practice: Survey Results of Rheumatologists and Dermatologists
JF  - RHEUMATOLOGY AND THERAPY
VL  - 9
IS  - 6
SP  - 1575-1586
EP  - 1575-1586
PB  - SPRINGER
SN  - 21986576
KW  - Women of childbearing age
KW  - Family planning
KW  - Chronic inflammatory disease
KW  - Rheumatoid arthritis
KW  - Psoriatic arthritis
KW  - Psoriasis
KW  - Reproductive health
UR  - https://link.springer.com/article/10.1007/s40744-022-00488-z
N2  - Introduction The proportion of women being treated with biologics is growing. However, data on treatment recommendation awareness among treating physicians and women who are considering pregnancy and family planning are limited. In this study, we used a questionnaire survey to learn how rheumatologists and dermatologists address women's needs for family planning, pregnancy, and breastfeeding, as well as their possible concerns with concurrent inflammatory rheumatic disease or psoriasis. Methods A 55-question (in English) survey aimed at identifying surveyed physicians' current practices regarding the reproductive health needs of women with rheumatoid arthritis, psoriasis, or psoriatic arthritis. This survey included 82 rheumatologists and 38 dermatologists from the Czech Republic, Hungary, and Slovakia. Results The proportion of female patients of reproductive age with the moderate-to-severe disease was 10-30% of all patients treated by the respondents. At the time of diagnosis, approximately two-thirds of the respondents discussed family planning with their patients. Rheumatologists collaborated with other specialists more frequently than dermatologists and gynecologist-obstetricians. Half of the rheumatologists revised systemic treatment 6 months before the patient planned to become pregnant, whereas dermatologists appear to act much sooner. Rheumatologists chose systemic glucocorticoids as the first-line treatment for pregnancy flares, whereas dermatologists chose topical corticosteroids. Congresses and interdisciplinary forums were rated the most valuable sources of information by physicians. Conclusions There is a need for more holistic, multidisciplinary, collaborative, and integrated communication between clinicians and women of childbearing age. Physicians should consider the implications of these conditions and medical treatment for women of childbearing age and family planning for those with rheumatoid arthritis and psoriatic disease. Patient-centered care that includes patients' reproductive choices should be a routine clinical practice.
ER  -

OLEJAROVA, Marta, Zelmira MACEJOVA, Spyridon GKALPAKIOTIS, Leona PROCHÁZKOVÁ, Zoltan TOTH and Pavel PRAGR. Reproductive Healthcare in Women with Rheumatoid Arthritis and Psoriatic Diseases in Routine Clinical Practice: Survey Results of Rheumatologists and Dermatologists. \textit{RHEUMATOLOGY AND THERAPY}. NEW YORK: SPRINGER, 2022, vol.~9, No~6, p.~1575-1586. ISSN~2198-6576. Available from: https://dx.doi.org/10.1007/s40744-022-00488-z.

Detailed Information on Publication Record